Biomedical Engineering Reference
In-Depth Information
Singh KK, Vingkar SK (2008) Formulation, antimalarial activity and biodistribution of oral lipid
nanoemulsion of primaquine. Int J Pharm 347 (1-2):136-143. doi:S0378-5173(07)00552-2
[pii] 10.1016/j.ijpharm.2007.06.035
Singh Y, Palombo M, Sinko PJ (2008) Recent trends in targeted anticancer prodrug and conjugate
design. Curr Med Chem 15 (18):1802-1826
Slutter B, Plapied L, Fievez V, Sande MA, des Rieux A, Schneider YJ, Van Riet E, Jiskoot W,
Preat V (2009) Mechanistic study of the adjuvant effect of biodegradable nanoparticles in
mucosal vaccination. J Control Release 138 (2):113-121. doi:S0168-3659(09)00299-5 [pii]
10.1016/j.jconrel.2009.05.011
Sparreboom A, van Asperen J, Mayer U, Schinkel AH, Smit JW, Meijer DK, Borst P, Nooijen WJ,
Beijnen JH, van Tellingen O (1997) Limited oral bioavailability and active epithelial excretion
of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci U S A 94
(5):2031-2035
Stremmel W (1988) Uptake of fatty acids by jejunal mucosal cells is mediated by a fatty acid
binding membrane protein. J Clin Invest 82 (6):2001-2010. doi:10.1172/JCI113820
Sugano K, Kansy M, Artursson P, Avdeef A, Bendels S, Di L, Ecker GF, Faller B, Fischer H,
Gerebtzoff G, Lennernaes H, Senner F (2010) Coexistence of passive and carrier-mediated
processes in drug transport. Nat Rev Drug Discov 9 (8):597-614. doi:nrd3187 [pii] 10.1038/
nrd3187
Sun B, Ranganathan B, Feng SS (2008) Multifunctional poly(D,L-lactide-co-glycolide)/mont-
morillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy
of breast cancer. Biomaterials 29 (4):475-486. doi:S0142-9612(07)00790-9 [pii] 10.1016/j.
biomaterials.2007.09.038
Takiuchi H, Ajani JA (1998) Uracil-tegafur in gastric carcinoma: a comprehensive review. J Clin
Oncol 16 (8):2877-2885
Terwogt JM, Schellens JH, Huinink WW, Beijnen JH (1999) Clinical pharmacology of anticancer
agents in relation to formulations and administration routes. Cancer Treat Rev 25 (2):83-101.
doi:10.1053/ctrv.1998.0107 S0305-7372(98)90107-4 [pii]
Thorne SH, Barak Y, Liang W, Bachmann MH, Rao J, Contag CH, Matin A (2009) CNOB/ChrR6,
a new prodrug enzyme cancer chemotherapy. Mol Cancer Ther 8 (2):333-341. doi:1535-7163.
MCT-08-0707 [pii] 10.1158/1535-7163.MCT-08-0707
Thummel KE (2007) Gut instincts: CYP3A4 and intestinal drug metabolism. J Clin Invest 117
(11):3173-3176. doi:10.1172/JCI34007
Trevaskis NL, Charman WN, Porter CJ (2008) Lipid-based delivery systems and intestinal
lymphatic drug transport: a mechanistic update. Adv Drug Deliv Rev 60 (6):702-716.
doi:S0169-409X(07)00315-8 [pii] 10.1016/j.addr.2007.09.007
van Herwaarden AE, Wagenaar E, van der Kruijssen CM, van Waterschoot RA, Smit JW, Song
JY, van der Valk MA, van Tellingen O, van der Hoorn JW, Rosing H, Beijnen JH, Schinkel AH
(2007) Knockout of cytochrome P450 3A yields new mouse models for understanding xeno-
biotic metabolism. J Clin Invest 117 (11):3583-3592. doi:10.1172/JCI33435
van Waterschoot RA, Rooswinkel RW, Wagenaar E, van der Kruijssen CM, van Herwaarden AE,
Schinkel AH (2009) Intestinal cytochrome P450 3A plays an important role in the regulation
of detoxifying systems in the liver. FASEB J 23 (1):224-231. doi:fj.08-114876 [pii] 10.1096/
fj.08-114876
Varma MV, Perumal OP, Panchagnula R (2006) Functional role of P-glycoprotein in limiting
peroral drug absorption: optimizing drug delivery. Curr Opin Chem Biol 10 (4):367-373.
doi:S1367-5931(06)00084-6 [pii] 10.1016/j.cbpa.2006.06.015
Wacher VJ, Salphati L, Benet LZ (2001) Active secretion and enterocytic drug metabolism barriers
to drug absorption. Adv Drug Deliv Rev 46 (1-3):89-102. doi:S0169-409X(00)00126-5 [pii]
Watkins PB (1997) The barrier function of CYP3A4 and P-glycoprotein in the small bowel. Adv
Drug Deliv Rev 27 (2-3):161-170. doi:S0169-409X(97)00041-0 [pii]
Weingart SN, Brown E, Bach PB, Eng K, Johnson SA, Kuzel TM, Langbaum TS, Leedy RD,
Muller RJ, Newcomer LN, O'Brien S, Reinke D, Rubino M, Saltz L, Walters RS (2008)
NCCN Task Force Report: Oral chemotherapy. J Natl Compr Canc Netw 6 Suppl 3:S1-14
Search WWH ::
Custom Search